CT

Collin Terpstra

North America, California, United States

Description

Collin Terpstra is an allergy specialist.

Investor Profile

Collin Terpstra has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in Canada.
  • Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.

Stage Focus

  • Series A (100%)

Country Focus

  • Canada (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Collin Terpstra frequently co-invest with?

Draper Associates
North America, California, United States, San Mateo
Co-Investments: 1
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 1
Business Development Bank of Canada
North America, Quebec, Canada, Montréal
Co-Investments: 1
BoxOne Ventures
North America, Quebec, Canada, Montréal
Co-Investments: 1
1517 Fund
North America, California, United States, Oakland
Co-Investments: 1
OS Fund
North America, Illinois, United States, Chicago
Co-Investments: 1
Cur8 Capital
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Collin Terpstra?

Kenota Health

Kitchener, Ontario, Canada

Kenota Health develops next-generation diagnostic tools intended to be used for allergy testing in humans.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series ADec 7, 2020
Amount Raised: $9,000,000